A combination of emetine hydrochloride or dehydroemetine with tetracycline and a 'luminal' amoebicide such as diloxanide furoate was for several years regarded as the treatment of choice for severe cases of amoebic dysentery in adults (Wilmot, 1966; Powell, 1967 Powell, , 1969a . In African children, who are frequently malnourished and suffering from additional diseases, amoebic dysentery is a serious condition. The onset is often acute and should complications occur the prognosis is worse than in adults (Scragg, 1960; Wilmot, 1962; Scragg and Powell, 1966, 1970) . Thus in the past it was our practice to use the combined regimen in all children with amoebic dysentery. The introduction of metronidazole was one of the most significant advances in the treatment of amoebiasis in recent years (World Health Organization, 1969) . It has been shown (Powell, Wilmot, and Elsdon-Dew, 1967; Powell, 1972) to be outstandingly effective in the treatmnent of invasive amoebiasis and, since it combines both intestinal and systemic activity, it has until now been regarded as the single drug of choice in this disease. Our studies have shown that metronidazole alone, given orally in divided daily doses for 5-7 days, is as effective as the previously favoured combined regimen of amoebicides in children with amoebic dysentery (Rubidge, Scragg, 50 mg/kg in divided daily doses for 5 days in the absence of any other drug therapy is effective in curing the majority of children with the complication of amoebic liver abscess. It is a safe and simple form of treatment.
Since these studies there is evidence (Welling and Monroe, 1972; Taylor, Migliardi, and Schach von Wittenau, 1970; Howes, Lynch, and Kivlin, 1970) that tinidazole, the most recent derivative of the nitroimidazole group of compounds, at a lower dose achieves significantly higher peak serum concentrations than metronidazole, and that serum levels of tinidazole immediately before a subsequent dose are approximately threefold higher than those of metronidazole. Thus tinidazole appears to be particularly well suited for the treatment of systemic amoebiasis. The drug has been shown to be very effective in amoebiasis in adults, and in the absence of a luminal amoebicide tinidazole, as a single drug, has given excellent results in the treatment of amoebic dysentery and amoebic liver abscess (Powell, 1975; Zuberi and Ibrahim, 1973; Misra and Laiq, 1974; Lewis, Cook, and Adeleye, 1974; Nava, Metlich, and Marti, 1974; de Esesarte, 1974; Prakash, Bansal, and Bansal, 1974; Gaber et al., 1975) . The drug has been well tolerated and free from toxic effects. On the basis of this information the present trial was designed to determine the efficacy of tinidazole in treatment of children in Durban with acute amoebic dysentery.
Material and methods
Thirty African children, aged 7 months to 11 years (mean age 3 years), were treated in hospital. All had acute amoebic dysentery with haematophagous Ent. histolytica in their stools. All were kept in hospital for a minimum of 28 days after starting treatment. Repeated stools were examined by direct smear and zinc sulphate flotation after completion of therapy. Before the start of therapy full blood counts, liver function tests, blood ureas, and urine examations were done in all and were repeated on days 7, 14, 21, and 28.
Based on the adult dose of 2 g tinidazole daily, the dose was adjusted according to the percentage method of Catzel (1974) and was given in a single dose in the moming for 3 consecutive days. However, the body weight of all were recorded and on a weight basis the mean dose was 63 mg/kg per day. Final assessment was made at 28 days. However, only 3 cases remained under observation for as short a period as this. In the remainder stools were examined over periods extending up to many months (Table I) . Results (Table II) The results were classified into the following categories. Cure: symptom-free and Ent. histolytica absent. Parasitic failure: persistence or recurrence of either trophozoites or cysts of Ent. histolytica after completion of therapy. Cure was obtained in all but 2 cases. These 2 rapidly became symptom metronidazole, where the cure rate was 85% in children with amoebic dysentery using a divided dose based on weight for 5-7 days (Rubidge et al., 1970; Watson, Leary, and Hartley, 1970) . In adults with amoebic dysentery (Powell, Wilmot, and Elsdon-Dew (1969) and Powell (1972) , using a single daily dose of metronidazole for 2-3 days, reported cure in 90-95%. We have not undertaken a trial of single daily doses of metronidazole in children with amoebic dysentery or amoebic liver abscess. However, in view of the results in adults it is likely that the same favourable result would be obtained. Such a trial is now under way.
As the exact ages of our African children are often in doubt and as many are much below the normal weight for age, it is preferable to recommend a dosage based on weight rather than age. It seems reasonable therefore to undertake further trials with tinidazole in order to establish the optimum dose based on actnal body weight.
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